Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GFRA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDC25C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM53C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF20A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NME5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNT8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REEP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM13B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on